Evidence map›Paper›PMID 33204676›Full record

ArticleERJ open research2020

Translating scientific discoveries during pandemics: ensuring equity for people affected by COVID-19 and tuberculosis.

Jessica Carter, Jon S Friedland, Daniela E Kirwan, Ruvandhi R Nathavitharana

Abstract readEditorial
In one paragraph

Article in ERJ open research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jessica CarterInstitute for Infection and Immunity, St George's, University of London, London, UK.
Jon S FriedlandInstitute for Infection and Immunity, St George's, University of London, London, UK.ORCID https://orcid.org/0000-0001-7789-9649
Daniela E KirwanInstitute for Infection and Immunity, St George's, University of London, London, UK.ORCID https://orcid.org/0000-0003-3989-0795
Ruvandhi R NathavitharanaDivision of Infectious Diseases, Beth Israel Deaconess Medical Center and Harvard Medical School Boston, Boston, MA, USA.ORCID https://orcid.org/0000-0002-3544-5021

Funding

Optimizing Diagnostic Strategies for TB Transmission Control in Health-Care FacilitiesK23AI132648 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI NATHAVITHARANA, RUVANDHI · 2018 to 2022
$945k
Department of Health NIHR300290Medical Research Council MR/P019978/1Medical Research Council MR/P019978/2NIAID NIH HHS K23 AI132648
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33204676
PMCPMC7659031

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.